In November 2015, Nature Reviews Neurology (originally published as Nature Clinical Practice Neurology) celebrates 10 years since the journal launch. To mark this occasion, we present a special Anniversary issue. A series of Decade in Review articles summarize major advances in the neurology field over the past decade. We also present a Viewpoint in which a panel of neurologists outline their predictions and priorities for the next 10 years. In addition, an Essay pays tribute to Jack Griffin, our launch Editor-in-Chief, and an Opinion article highlights the importance of preserving brain health in our ageing population. Finally, a special infographic provides a snapshot of 10 years of the journal in numbers.
Editorial
Nature Reviews Neurology: the early years
Heather Wood
doi:10.1038/nrneurol.2015.204
Nature Reviews Neurology 11, 607 (2015)
Decade in Reviews
Decade in review–dementia: A decade of discovery and disappointment in dementia research
John R. Hodges
doi:10.1038/nrneurol.2015.191
Nature Reviews Neurology 11, 613-614 (2015)
Decade in review—multiple sclerosis: New drugs and personalized medicine for multiple sclerosis
Paul M. Matthews
doi:10.1038/nrneurol.2015.200
Nature Reviews Neurology 11, 614-616 (2015)
Decade in review—epilepsy: Edging toward breakthroughs in epilepsy diagnostics and care
Daniel H. Lowenstein
doi:10.1038/nrneurol.2015.193
Nature Reviews Neurology 11, 616-617 (2015)
Decade in review—movement disorders: Tracking the pathogenesis of movement disorders
Oksana Suchowersky
doi:10.1038/nrneurol.2015.201
Nature Reviews Neurology 11, 618-619 (2015)
Decade in review–stroke: Progress in acute ischaemic stroke treatment and prevention
Jose G. Romano & Ralph L. Sacco
doi:10.1038/nrneurol.2015.199
Nature Reviews Neurology 11, 619-621 (2015)
Decade in review—migraine: Incredible progress for an era of better migraine care
Peter J. Goadsby
doi:10.1038/nrneurol.2015.203
Nature Reviews Neurology 11, 621-622 (2015)
Decade in review—CNS infections: Major advances against a moving target of CNS infections
Lisa F. P. Ng & Tom Solomon
doi:10.1038/nrneurol.2015.202
Nature Reviews Neurology 11, 623-624 (2015)
Perspectives
Progress in inflammatory neuropathy —the legacy of Dr Jack Griffin
Eva L. Feldman, Richard A. C. Hughes & Hugh J. Willison
doi:10.1038/nrneurol.2015.192
Nature Reviews Neurology 11, 646-650 (2015)
John W. 'Jack' Griffin (1942–2011) was the launch Editor-in-Chief of Nature Clinical Practice Neurology, and continued to serve on the Advisory Board after the journal was rebranded as Nature Reviews Neurology in 2009. In this Essay, the authors pay tribute to Jack, highlighting his seminal contributions to the field of inflammatory neuropathies, and reviewing recent progress in this area, including the emergence of the node of Ranvier as a site of intensive investigation.
Brain health and shared risk factors for dementia and stroke
Hannah Gardener, Clinton B. Wright, Tatjana Rundek & Ralph L. Sacco
doi:10.1038/nrneurol.2015.195
Nature Reviews Neurology 11, 651-657 (2015)
The risk factors for cardiovascular disease are largely the same as those that harm brain health, and—importantly—these shared risk factors are modifiable. This Perspectives article discusses how the conceptual shift from avoiding vascular risk factors to promoting brain health creates opportunities for reducing morbidity and mortality associated with poor brain health.
Neurology—the next 10 years
Ralf Baron, Donna M. Ferriero, Giovanni B. Frisoni, Chetan Bettegowda, Ziya L. Gokaslan, John A. Kessler, Annamaria Vezzani, Stephen G. Waxman, Sven Jarius, Brigitte Wildemann & Michael Weller
doi:10.1038/nrneurol.2015.196
Nature Reviews Neurology 11, 658-664 (2015)
Since the launch of Nature Clinical Practice Neurology in 2005, we have seen remarkable progress in many areas of neurology research, but what does the future hold? For this special Viewpoint article, we invited a panel of Advisory Board members and other journal contributors to outline their research priorities and predictions for the next 10 years.